Louis V Puneky MD

Oncology•Jackson, MS

Associate Professor, Medicine, University of Mississippi School of Medicine

Join to View Full Profile

2500 North State StreetDepartment of Medicinedivision of OncologyJackson, MS 39216
Phone+1 601-984-5590
Fax+1 601-984-5599

Education & Training

University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
University of Mississippi Medical CenterResidency, Internal Medicine, 1985 - 1988
Louisiana State University School of Medicine in New OrleansClass of 1985

Certifications & Licensure

MS State Medical License 1986 - 2025
LA State Medical License 1985 - 2000
AL State Medical License 1990 - 1994
American Board of Internal Medicine Internal Medicine

Clinical Trials

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
ACTIVE_NOT_RECRUITING
PHASE3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 2
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
ACTIVE_NOT_RECRUITING
PHASE3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
ACTIVE_NOT_RECRUITING
PHASE3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Wade O Christopher, Truman M Earl, Louis V Puneky, Ashley H Seawright, James J Wynn
The American surgeon. 2017-09-30
Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Wade O Christopher, Truman M Earl, Louis V Puneky, Ashley H Seawright, James J Wynn
The American surgeon. 2017-09-01
2 citations
Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Wade O. Christopher, Truman M. Earl, Louis V. Puneky, A.H. Seawright, James J. Wynn
The American Surgeon. 2017-09-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member